Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm C Pike

Showing results (151-160 of 252) with videos related to

Pageof 26
Sort By:
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Breast Cancer Research : BCR|September 22, 2006
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)David G Cox, Hélène Blanché, Celeste L Pearce, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Fertility and Sterility|August 20, 2010
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effortAimee M Near, Anna H Wu, Claire Templeman, et al.
International Journal of Cancer|October 16, 2007
Haplotypes of the estrogen receptor beta gene and breast cancer risk, David G Cox, Philip Bretsky, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Pageof 26

Showing results (151-160 of 252) with videos related to

Sort By:
Pageof 26
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Breast Cancer Research : BCR|September 22, 2006
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)David G Cox, Hélène Blanché, Celeste L Pearce, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Fertility and Sterility|August 20, 2010
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effortAimee M Near, Anna H Wu, Claire Templeman, et al.
International Journal of Cancer|October 16, 2007
Haplotypes of the estrogen receptor beta gene and breast cancer risk, David G Cox, Philip Bretsky, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Pageof 26